Psychedelic Drugs - American College of Neuropsychopharmacology
... As defined in this chapter, the term psychedelic drugs includes both classic hallucinogens [i.e., indolalkylamines and phenylalkylamines, such as lysergic acid diethylamide (LSD) and mescaline, respectively], ‘‘dissociative’’ drugs [i.e., arylcyclohexamines, such as phencyclidine (PCP) and ketamine] ...
... As defined in this chapter, the term psychedelic drugs includes both classic hallucinogens [i.e., indolalkylamines and phenylalkylamines, such as lysergic acid diethylamide (LSD) and mescaline, respectively], ‘‘dissociative’’ drugs [i.e., arylcyclohexamines, such as phencyclidine (PCP) and ketamine] ...
Tinospora crispa – a review
... Thai folk remedies for maintaining good health. A decoction of the stems, leaves and roots is used to treat fever, cholera, diabetes, rheumatism and snake-bites, an infusion of the stem is drunk as a vermifuge, a decoction of the stem is used for washing sore eyes and syphilitic sores, the crushed l ...
... Thai folk remedies for maintaining good health. A decoction of the stems, leaves and roots is used to treat fever, cholera, diabetes, rheumatism and snake-bites, an infusion of the stem is drunk as a vermifuge, a decoction of the stem is used for washing sore eyes and syphilitic sores, the crushed l ...
The effectiveness of buprenorphine in treating opioid
... Harris, D. S., Jones, R. T., Welm, S., Upton, R. A., Lin, E., & Mendelson, J. (2000). Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug and Alcohol Dependence, 61, 85-94. doi: S0376-8716(00)00126-5 McHugh, R. K., DeVito, E. E., Dod ...
... Harris, D. S., Jones, R. T., Welm, S., Upton, R. A., Lin, E., & Mendelson, J. (2000). Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug and Alcohol Dependence, 61, 85-94. doi: S0376-8716(00)00126-5 McHugh, R. K., DeVito, E. E., Dod ...
Nicotine and Schizophrenia
... • Improved working memory with nicotine patch and increased (fMRI) activation in anterior cingulate and bilateral thalamus (Jacobsen 2004) • Lack of improvement in verbal memory with nicotine gum/patch (Levin 1996; Harris 2004) ...
... • Improved working memory with nicotine patch and increased (fMRI) activation in anterior cingulate and bilateral thalamus (Jacobsen 2004) • Lack of improvement in verbal memory with nicotine gum/patch (Levin 1996; Harris 2004) ...
Administration of the Combination Clonazepam
... To prevent the clonazepam intake from jeopardizing the comparison between treatment outcomes after Deanxit or placebo, the group assignment (A or B) was added as factor in the general model of repeated measures. This taken into consideration, both outcomes of Treatments 1 and 2 could be compared wit ...
... To prevent the clonazepam intake from jeopardizing the comparison between treatment outcomes after Deanxit or placebo, the group assignment (A or B) was added as factor in the general model of repeated measures. This taken into consideration, both outcomes of Treatments 1 and 2 could be compared wit ...
Dopamine Hypothesis of Mania
... precursor in synthesis of the cat-echolamine neurotransmitters noradrenaline (norepinephrine) and adrenaline (epinephrine). In 1957 it was shown to be present in the brain with other catecholamines (1). In 1958, Carlsson discovered the function of dopamine a neurotransmitter (2), while studying the ...
... precursor in synthesis of the cat-echolamine neurotransmitters noradrenaline (norepinephrine) and adrenaline (epinephrine). In 1957 it was shown to be present in the brain with other catecholamines (1). In 1958, Carlsson discovered the function of dopamine a neurotransmitter (2), while studying the ...
Principles of Toxicology
... relevance, theses examples also emphasize the value of understanding the mechanism of action of the poison. Knowing the mechanism, then, is the foundation for developing an antidote and assessing risk. b. We’ll talk about some toxic metals too (like arsenic, lead, mercury). 1. Mercury has particular ...
... relevance, theses examples also emphasize the value of understanding the mechanism of action of the poison. Knowing the mechanism, then, is the foundation for developing an antidote and assessing risk. b. We’ll talk about some toxic metals too (like arsenic, lead, mercury). 1. Mercury has particular ...
Phenylephrine Hydrochloride
... exceed 0.5 mg and that subsequent doses may be increased in increments of 0.1–0.2 mg, depending on the blood pressure response of the patient. Systolic blood pressure should not be raised above 160 mm Hg. The maximum single dose of phenylephrine hydrochloride recommended by the manufacturer is 1 mg. ...
... exceed 0.5 mg and that subsequent doses may be increased in increments of 0.1–0.2 mg, depending on the blood pressure response of the patient. Systolic blood pressure should not be raised above 160 mm Hg. The maximum single dose of phenylephrine hydrochloride recommended by the manufacturer is 1 mg. ...
Naturally Occurring and Related Synthetic Cannabinoids and their
... In vivo Testing of endocannabinoids produce behavioral and pharmacological actions associated with other cannabimimetic ligands. Anandamide (5a) produces antinociception, hypothermia, hypomobility, and catalepsy in the mouse tetrad model, with rapid onset of effects, but with a short duration of act ...
... In vivo Testing of endocannabinoids produce behavioral and pharmacological actions associated with other cannabimimetic ligands. Anandamide (5a) produces antinociception, hypothermia, hypomobility, and catalepsy in the mouse tetrad model, with rapid onset of effects, but with a short duration of act ...
Clinical application of extended-release hydromorphone for pain
... countries. For example, there is a 12-h formulation available in Canada (Hydromorph Contin) and the UK and Germany (Palladone SR) [1] . Additionally, Palladone XL, a 24-h preparation, was approved for use in Canada [1] . Like OROS hydromorphone, the advantages of the Palladone formulations are a sim ...
... countries. For example, there is a 12-h formulation available in Canada (Hydromorph Contin) and the UK and Germany (Palladone SR) [1] . Additionally, Palladone XL, a 24-h preparation, was approved for use in Canada [1] . Like OROS hydromorphone, the advantages of the Palladone formulations are a sim ...
Amiodarone and beta blockade
... is the Whole Better than Parts? A. V. Ghuran, A. J. Camm Amiodarone and beta-blockers are the two most widely used antiarrhythmic drugs. Although these agents share similar properties, they also have distinct pharmacological, pharmacokinetic and electrophysiological differences. Recent data suggest ...
... is the Whole Better than Parts? A. V. Ghuran, A. J. Camm Amiodarone and beta-blockers are the two most widely used antiarrhythmic drugs. Although these agents share similar properties, they also have distinct pharmacological, pharmacokinetic and electrophysiological differences. Recent data suggest ...
The Benzo Manual
... Adverse effects in the elderly. Older people are more sensitive than younger people to the central nervous system depressant effects of benzodiazepines. Benzodiazepines can cause confusion, night wandering, amnesia, ataxia (loss of balance), hangover effects and "pseudodementia" (sometimes wrongly a ...
... Adverse effects in the elderly. Older people are more sensitive than younger people to the central nervous system depressant effects of benzodiazepines. Benzodiazepines can cause confusion, night wandering, amnesia, ataxia (loss of balance), hangover effects and "pseudodementia" (sometimes wrongly a ...
Advancesin the Treatment of Crohn`s Disease
... budesonide in North American patients, which showed improved responses compared with placebo during active disease but no efficacyover placebo for remission induction.7 Because of significantly less adrenal suppression and other glucocorticoid side effects, controlled ileal release budesonide is pre ...
... budesonide in North American patients, which showed improved responses compared with placebo during active disease but no efficacyover placebo for remission induction.7 Because of significantly less adrenal suppression and other glucocorticoid side effects, controlled ileal release budesonide is pre ...
as a PDF
... transplant rejection). Clinically applied dosage regimens have been derived empirically and there is considerable variability between patients in clinical response to glucocorticoid treatment. The pharmacokinetics and pharmacodynamics of glucocorticoids have therefore been evaluated in many studies. ...
... transplant rejection). Clinically applied dosage regimens have been derived empirically and there is considerable variability between patients in clinical response to glucocorticoid treatment. The pharmacokinetics and pharmacodynamics of glucocorticoids have therefore been evaluated in many studies. ...
Examination of Cholinergic Activity during Nicotine
... CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE 9th Drug Abuse Research Symposium September 12, 2014 ...
... CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE 9th Drug Abuse Research Symposium September 12, 2014 ...
Therapy Insight: drugs for gastrointestinal disorders in pregnant
... A), administered at a dose of 10–25 mg three times daily, was shown to improve NVP in two small studies.5,6 ...
... A), administered at a dose of 10–25 mg three times daily, was shown to improve NVP in two small studies.5,6 ...
Dopamine receptor agonist treatment of Parkinson`s disease
... 1% of individuals over 60 years of age. There has been a growing interest in dopamine agonists as a form of treatment for this disease. The aims of this systematic review and metaanalysis were to establish the efficacy of different subclasses of dopamine receptor agonist in the treatment of animal m ...
... 1% of individuals over 60 years of age. There has been a growing interest in dopamine agonists as a form of treatment for this disease. The aims of this systematic review and metaanalysis were to establish the efficacy of different subclasses of dopamine receptor agonist in the treatment of animal m ...
Medication used in the Treatment of Parkinson`s
... dopamine that is lost in Parkinson’s. The drugs are usually started at a low dose and increased slowly to reduce any possible side effects. Several clinical studies have shown that dopamine agonists can be effective treatments for several years when used alone and the likelihood of developing dyskin ...
... dopamine that is lost in Parkinson’s. The drugs are usually started at a low dose and increased slowly to reduce any possible side effects. Several clinical studies have shown that dopamine agonists can be effective treatments for several years when used alone and the likelihood of developing dyskin ...
a review on the pharmacology of embelia ribes burm.f.
... The anticonvulsant activity of embelin was studied at different dosages namely 2.5, 5 and 10mg/kg. It showed a significant inhibition of the seizures induced by electroshock and the drug pentylenetetrazole in a dose dependent manner. This activity was compared to the market standard drugs phenytoin ...
... The anticonvulsant activity of embelin was studied at different dosages namely 2.5, 5 and 10mg/kg. It showed a significant inhibition of the seizures induced by electroshock and the drug pentylenetetrazole in a dose dependent manner. This activity was compared to the market standard drugs phenytoin ...
Controlled Substance Prior Authorization
... REMS, while transmucosal products are included in the TIRF Shared REMS. The FDA-approved transmucosal immediaterelease fentanyl (TIRF) REMS program consists of a Medication Guide, and Element To Assure Safe Use that includes a restricted distribution system requiring prescriber certification, and en ...
... REMS, while transmucosal products are included in the TIRF Shared REMS. The FDA-approved transmucosal immediaterelease fentanyl (TIRF) REMS program consists of a Medication Guide, and Element To Assure Safe Use that includes a restricted distribution system requiring prescriber certification, and en ...
The Protective Role of Extract of Allium cepa Linn. (Liliaceae) (Red
... Artesunate is one of the numerous drugs for effectively treating malaria in Nigeria. Artesunate (AS) is a clinically versatile Artemisinin derivative utilized for the treatment of mild to severe malaria infection. It may be administered via intravenous (IV), intramuscular (IM), oral or rectal routes ...
... Artesunate is one of the numerous drugs for effectively treating malaria in Nigeria. Artesunate (AS) is a clinically versatile Artemisinin derivative utilized for the treatment of mild to severe malaria infection. It may be administered via intravenous (IV), intramuscular (IM), oral or rectal routes ...
Bilastine
Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma.Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine meets the current European Academy of Allergy and Clinical Immunology (EAACI) and Allergic Rhinitis and its Impact of Asthma (ARIA) criteria for medication used in the treatment of allergic rhinitis.Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.